ArticleOncogene2022
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
Patience Odeniyide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it
ArticleOncogene2022
Patience Odeniyide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.